Goldenwell Biotech, Inc.
- Jurisdiction
United States - ISIN
US38138N1046 (GWLL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. Read full profile
Stock price
Fundamentals
- Net revenue
€32.04K - Gross margin
100.2% - EBIT
-€66.58K - EBIT margin
-207.8% - Net income
-€77.39K - Net margin
-241.5%
Statement period: - (published )
Dividends
No dividend payouts